Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneum01:21

Peritoneum

The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal hyperparathyroidism: comparative outcomes of parathyroidectomy in two regional centres over 14 years.

Annals of the Royal College of Surgeons of England·2026
Same author

Donor noradrenaline use is associated with better allograft survival in recipients of pancreas transplantation.

Annals of the Royal College of Surgeons of England·2023
Same author

Future imaging modalities for the assessment of pancreas allografts a scan of the horizon.

Transplantation reviews (Orlando, Fla.)·2022
Same author

Impact of Impaired Kidney Function on Outcomes of Nigerians with COVID-9 Infection: Report of Two Cases from the University College Hospital, Ibadan.

West African journal of medicine·2021
Same author

Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death.

The British journal of surgery·2019
Same author

Rapid on-site evaluation facilitated the diagnosis of a rare case of Talaromyces marneffei infection.

Cytopathology : official journal of the British Society for Clinical Cytology·2018
Same journal

Proceedings of the 5th Annual UAB-UCSD O'Brien Center Symposium, March 4, San Diego, California.

Nephron. Clinical practice·2015
Same journal

Proceedings of the 19th International Conference on Continuous Renal Replacement Therapies, March 2-3, 2014, San Diego, California, USA.

Nephron. Clinical practice·2015
Same journal

Chronic kidney disease in disadvantaged populations.

Nephron. Clinical practice·2015
Same journal

Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy.

Nephron. Clinical practice·2015
Same journal

Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Nephron. Clinical practice·2015
Same journal

Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction.

Nephron. Clinical practice·2015
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Encapsulating peritoneal sclerosis: clinical significance and implications.

T Augustine1, P W Brown, S D Davies

  • 1Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK.

Nephron. Clinical Practice
|January 17, 2009
PubMed
Summary
This summary is machine-generated.

Encapsulating peritoneal sclerosis (EPS), a serious complication of peritoneal dialysis (PD), requires better understanding. This review covers EPS aetiology, pathogenesis, diagnosis, and highlights surgery as a key treatment option.

More Related Videos

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

Related Experiment Videos

Last Updated: Jun 26, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

Area of Science:

  • Nephrology
  • Gastroenterology
  • Pathology

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a rare, severe complication of peritoneal dialysis (PD).
  • Distinguishing EPS from simple peritoneal membrane sclerosis is crucial for accurate diagnosis and management.
  • Current understanding of EPS aetiology and pathogenesis requires further elucidation.

Purpose of the Study:

  • To review the current knowledge on the aetiology and pathogenesis of Encapsulating Peritoneal Sclerosis (EPS).
  • To outline diagnostic criteria for EPS, including the utility of imaging modalities.
  • To discuss therapeutic strategies for EPS, emphasizing surgical interventions.

Main Methods:

  • Literature review of existing studies on Encapsulating Peritoneal Sclerosis (EPS).
  • Analysis of histological features differentiating EPS from other peritoneal pathologies.
  • Evaluation of current diagnostic and therapeutic approaches for EPS.

Main Results:

  • Histological findings are key to differentiating EPS from chronic PD-induced peritoneal sclerosis.
  • Imaging techniques play a role in the diagnosis of EPS.
  • No randomized controlled trials currently guide EPS therapy, but surgical techniques are a viable option.

Conclusions:

  • Further collaborative research is essential to address the challenges posed by EPS in peritoneal dialysis patients.
  • Improved understanding of EPS pathogenesis may lead to more effective treatments.
  • Surgical intervention represents an important treatment modality for Encapsulating Peritoneal Sclerosis.